The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine, sources said. Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial protocol for administration of booster dose six months after the second dose.from IndiaTV India: Google News Feed https://ift.tt/39CzzuR
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.